3-4-dihydroxyphenyllactic-acid and Cardiovascular-Diseases

3-4-dihydroxyphenyllactic-acid has been researched along with Cardiovascular-Diseases* in 1 studies

Other Studies

1 other study(ies) available for 3-4-dihydroxyphenyllactic-acid and Cardiovascular-Diseases

ArticleYear
Cardiovascular Protective Effects of Salvianic Acid A on
    Oxidative medicine and cellular longevity, 2017, Volume: 2017

    The onsets of left ventricular hypertrophy (LVH) and endothelial dysfunction (ED) in diabetics, especially in those with elevated homocysteine (Hcy), precede the development of cardiovascular (CV) events. Salvianic acid A (SAA) is a renowned Traditional Chinese Medicine (TCM) that has been applied in the treatment of cardiovascular disease for many decades. In this study, we aimed (1) to investigate the CV protective effects of SAA on ameliorating LVH and ED in

    Topics: Animals; Cardiovascular Diseases; Echocardiography; Female; Hyperhomocysteinemia; Lactates; Mice

2017